Delivery Order SPE2DB22D7058-SPE2DB25FSWB4
Award Date
6/4/25
Potential Completion Date
6/5/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a firm fixed price delivery order between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The award is for the supply of HYZAAR 50-12.5 TABLET 30S, a pharmaceutical product, with a potential value of $1,102.08 and a completion date of February 13, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,415.58, is a Delivery Order for the procurement of HYZAAR 100-25 Tablets with an ultimate completion date of May 23, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of HYZAAR 50-12.5 tablets. The firm-fixed-price delivery order has a ceiling value of $1,904.22 and an ultimate completion date of December 12, 2023. The contract is not designated as a set-aside. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award is for the delivery of HYZAAR 100-12.5 TABLET 30S medication, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $9,635.71 firm fixed-price delivery order contract has a completion date of November 21, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and...
This federal contract award, with the ID SPE2DX15D2013|SPE2DX24F29S6, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,955.78 firm fixed-price delivery order is for the provision of HYZAAR 100-25 TABLET 30S, a pharmaceutical product, with a completion date of January 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $10,809.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award, with ID SPE2DB20D1100|SPE2DB24FC4F1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,270.92 firm fixed-price delivery order covers the supply of HYZAAR 50-12.5 TABLET 30S, a pharmaceutical product, with a performance period through June 26, 2024. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, with ID SPE2DB20D1004|SPE2DB25FNGTE, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,299.69 delivery order contract is for the supply of HYZAAR 50-12.5 TABLET 30S, a medication, and is a Firm Fixed Price contract. The award date is April 30, 2025, with a completion date of May 1, 2025. The contract is not set aside and is an open competition award....
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,973.76 contract is for the supply of HYZAAR 50-12.5 TABLET 30S, a pharmaceutical product, to be delivered by January 30, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,326.65 and is for the delivery of HYZAAR 100-12.5 TABLET 90S, a prescription medication. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...